B Cell News Today

notre—dame cathedral as restoration continues, four years since a fire destroyed significant parts of the world heritage landmark. hello, im lucy gray. the man arrested on suspicion of throwing a smoke bomb at japans prime minister fumio kishida has been identified by the authorities as 24—year—old ryuji kimura. there are no further details regarding possible motivation. mr kishida was about to give a speech in support of a local candidate of his ruling party the ldp. pm kishida ...

tractor trailers flipped after a string of tornadoes ripped across mississippi and alabama. >> we cant account for everybody and it just is hard. >> plus, the terrifying survivor stories. this woman hiding in a freezer. deadly explosion at a chocolate factory in pennsylvania. at least two people dead. one person found alive under the rubble, but others still missing. the blast so big, it rocked nearby buildings off their foundations. vladimir putins nuclear escalation. russia now m...

Two new self-amplifying mRNA vaccines herald a new era of vaccination for coronaviruses.

Researchers at Washington University School of Medicine in St. Louis have received a $6.2 million grant from the National Institutes of Health (NIH) to develop a gene therapy that would modify the immune system's B cells to spur them to produce broadly neutralizing antibodies against HIV.

Australian researchers have discovered a previously unknown rogue immune cell that can cause poor antibody responses in chronic viral infections.

Despite having an overall survival rate of 94%, B-cell acute lymphoblastic leukemia (B-ALL), the most common childhood cancer, can prove challenging to treat, with survival among relapsed or resistant cases falling between 30-50%.

CAR T-cell therapy involves modifying a patient’s T-cells—white blood cells that are integral to the immune system. The lab-modified cells are then infused in the patient to multiply and fight cancerous cells. The therapy costs $400,000 in the US and tenth of that in India. But, does it work?

Early in the pandemic, clinicians noticed that certain immunocompromised patients were experiencing persistent SARS-CoV-2 infections, some lasting weeks to months at a time.

In findings that have implications for potential new HIV therapies, researchers from Texas Biomedical Research Institute (Texas Biomed) used genetic sequencing techniques on the nonhuman primate version of the virus to identify that lymph nodes in the abdomen are the leading source of rebound infection after the first week of stopping antiretroviral treatment.

First order for IV-Cell placed by Major Japanese Laboratory...